Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception-Reference-Cited by-同舟云学术

Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception

Published:2020-06-22 Issue:7 Volume:13 Page:685-694
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Chiara Del Savio Maria¹,De Fata Riccardo¹,Facchinetti Fabio¹,Grandi Giovanni¹^ORCID

Affiliation:

1. Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Di Modena, 41124, Modena, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2020.1783247

Reference60 articles.

1. The progestogen-only mini-pill

2. Pharmacokinetic evaluation of desogestrel as a female contraceptive

3. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition ratio (I.R.) and transformation index (T.I.): new indexes to compare the effectiveness and clinical behaviour of modern progestin-only pills (POP);The European Journal of Contraception & Reproductive Health Care;2024-07-11

2. Metabolism of progestogens used for contraception and menopausal hormone therapy;Steroids;2024-07

3. Safety of Progestogen Hormonal Contraceptive Methods during Lactation: An Overview;Clinics and Practice;2024-06-04

4. Let’s reconsider modern progestin-only pills during isotretinoin and retinoid therapy;The European Journal of Contraception & Reproductive Health Care;2024-03

5. Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications;Expert Opinion on Drug Metabolism & Toxicology;2023-11-12